<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0806222155
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LOXTRA EYE DROP
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        OFLOXACIN,PREDNISOLONE,TETRAHYDROZOLINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3,2,0.4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        18.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        NA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Loxtra&trade; is a combination of drugs for<br />treatment of inflammatory conditions of the eye<br />where bacterial infection or risk of bacterial<br />infection exists.<br />&bull; Loxtra&trade; is prescribed for you if you have<br />corticosteroid responsive inflammatory condition<br />of the conjunctiva, cornea and anterior segment of<br />the eye where bacterial infection or a risk of<br />bacterial infection exists. Steroid-responsive<br />inflammations are those inflammatory disorders<br />that will respond to corticosteroid treatment.<br />&bull; It works by reducing the intensity of the acute<br />inflammatory response, killing the bacteria,<br />relieving the conjunctival congestion and<br />controlling the hyperemia.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Loxtra&trade;<br />&bull; If you are allergic (hypersensitive) to any of the<br />ingredients of Loxtra&trade;. Ask your doctor for<br />advice.<br />&bull; If you have previously had herpes simplex.<br />Take special care with Loxtra&trade;<br />&bull; If you have glaucoma or are being treated for<br />raised pressure within the eye.<br />&bull; In children under the age of 6 years.<br />Using other medicines<br />Please tell your doctor or pharmacist if you are<br />taking or have recently taken any other medicines,<br />including medicines obtained without a<br />prescription.<br />If you are using other eye drops at the same<br />time as Loxtra&trade;, follow the advice at the end of<br />section 3.<br />Pregnant women<br />If you are pregnant, or might get pregnant, talk to<br />your doctor before you use Loxtra&trade;.<br />Breast feeding women<br />If you are breast feeding. Ask your doctor for<br />advice before taking any medicine.<br />Driving and using machines<br />Your sight may become blurred for a short time<br />just after using Loxtra&trade;. You should not drive or<br />use machines until your sight is clear again.<br />Loxtra&trade; contains benzalkonium chloride<br />Contact lenses<br />&bull; Do not use the drops while your contact lenses<br />are in your eyes. Wait at least 15 minutes after<br />using the eye drops before putting your contact<br />lenses back in your eyes.<br />&bull; Loxtra&trade; should not be used whilst contact<br />lenses are in place, as it may discolour them.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use Loxtra&trade; exactly as your doctor has<br />told you. Check with your doctor or pharmacist if<br />you are not sure.<br />The usual dose is 1 or 2 drops in the eye(s), 3 to<br />4 times daily.<br />Use this much unless your doctor tells you to do<br />differently. Only use Loxtra&trade; in both eyes if your<br />doctor told you to. Use it for as long as your<br />doctor told you to.<br />Only use Loxtra&trade; as an eye drop.<br />Instructions for using eye drops<br />&bull; First wash your hands.<br />&bull; Shake the bottle well before use.<br />&bull; Remove the cap of the bottle.<br />&bull; Tilt your head back a little and pull the lower lid<br />of your eye downwards to form a pocket.<br />&bull; Hold the bottle upside down near to your eye.<br />&bull; Try not to touch your eye as you do this.<br />&bull; Apply enough pressure to release one drop into<br />your eye.<br />&bull; Close your eye for a minute or two, and press<br />gently on the side of your nose where the corner<br />of your eye meets your nose. This helps to stop<br />the drop from draining away and keeps it in your<br />eye.<br />&bull; Repeat the process in your other eye if it also<br />needs treatment.<br />&bull; After using the bottle, reclose it.<br />How much to use:<br />If a drop misses your eye, try again.<br />To avoid eye injury and contamination, do not let<br />the tip of the dropper touch your eye or anything<br />else.<br />If you use more Loxtra&trade; than you should rinse<br />it all out with warm water.<br />Don&#39;t put in any more drops until it&#39;s time for your<br />next regular dose.<br />If you forget to use Loxtra&trade;, use a single drop<br />as soon as you remember, and then go back to<br />your regular routine. Do not use a double dose to<br />make up for the one missed.<br />If you are using other eye drops, wait at least<br />five to ten minutes between putting in<br />Loxtra&trade; and the other drops.<br />If, by accident, anyone drinks this medicine,<br />contact your doctor straight away.<br />Do not stop using Loxtra&trade; until your doctor has<br />told you to.<br />If you have any further questions on the use of<br />this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Loxtra&trade; can cause side<br />effects, although not everybody gets them.<br />Side effects<br />Frequency categories: very common (&ge;1/10);<br />common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000<br />to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare<br />(&lt;1/10,000), not known (cannot be estimated from<br />available data).<br />Immune system disorders<br />Not known: Hypersensitivity, Urticaria<br />Nervous system disorders<br />Not known: Headache, Dizziness<br />Eye disorders<br />Common: Eye irritation; Ocular discomfort<br />Not known: Intraocular pressure increased;<br />Cataract (including subcapsular); Keratitis;<br />Conjunctivitis; Eye edema; Foreign body<br />sensation in eyes; Increased lacrimation; Dry eye;<br />Eye pain; Ocular hyperemia; Periorbital edema<br />(including eyelid edema); Eye penetration (scleral<br />or corneal perforation); Ocular infection<br />(including bacterial, fungal, and viral infections);<br />Ocular stinging; Eye irritation; Vision blurred<br />/Visual impairment; Mydriasis<br />Gastrointestinal disorders<br />Not known: Dysgeusia; Nausea<br />Skin and subcutaneous tissue disorders<br />Not known: Pruritus; Rash; Stevens-Johnson<br />syndrome; Toxic epidermal necrolysis<br />Systemic: extensive topical use of corticosteroids<br />may lead to systemic side effects<br />You can usually carry on taking the drops,<br />unless the effects are serious. If any of the side<br />effects gets serious, or if you notice any side<br />effects not listed in this leaflet, please tell your<br />doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; Do not store above 30 &ordm;C.<br />&bull; Loxtra&trade; eye drops are sterile when first opened,<br />it is important to keep the drops as clean as<br />possible during use.<br />&bull; Once opened the drops should not be used for<br />longer than 1 month.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each ml of Loxtra&trade; contains active substances:<br />ofloxacin 3.0 mg, prednisolone acetate 2.0 mg,<br />tetrahydrozoline hydrochloride 0.4 mg,<br />The other ingredients: benzalkonium chloride,<br />sodium chloride, hydroxypropylmethyl cellulose,<br />water for injection, hydrochloric acid 1N and/or<br />sodium hydroxide 1N (to adjust pH).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                • Loxtra™ ophthalmic suspension color is off
white to light yellow .
• Loxtra™ ophthalmic suspension, 5 ml filled in
LDPE bottle.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jamjoom Pharmaceuticals Co.,<br />Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and<br />Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                06/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>هو عبارة عن تركيبة من الأدوية تستخدم &trade; عقار لوكسترا<br />لعلاج حالات التهاب العين التي تحدث بسبب العدوى<br />البكتيرية أو خطر الإصابة بالعدوى البكتيرية.<br />لك إذا كنت تُعَاني من حالات &trade; - يتم وصف عقار لوكسترا<br />التهابات الملتحمة والقرنية والجزء الأمامي من العين والتي<br />تستجيب للكورتيكوستيرويدات حيث تحدث بسبب العدوى<br />البكتيرية أو خطر الإصابة بالعدوى البكتيرية. الالتهابات<br />التي تستجيب للستيرويدات هي تلك الاضطرابات الالتهابية<br />التي من شأنها الاستجابة للعلاج بالكورتيكوستيرويدات.<br />- يعمل هذا الدواء عن طريق تقليل شدة الالتهاب الحاد وقتل<br />البكتيريا وتخفيف احمرار الملتحمة والسيطرة على احتقان<br />العين</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تستخدم هذا العقار في الحالات التالية:<br />- إذا كنت تُعَاني من الحساسية (فرط الحساسية) تجاه أي<br />يُرجى .&trade; من المكونات الداخلة في تركيب عقار لوكسترا<br />استشارة الطبيب المعالج لك.<br />- إذا كنت قد عانيت مسبقًا من الهربس البسيط.<br />&trade; توخ حذرًا خاصًا عند استخدام عقار لوكسترا<br />- إذا كنت تُعَاني من الجلوكوما (المياه الزرقاء) أو إذا كنت<br />تخضع لعلاج الضغط المرتفع داخل العين.<br />- عند استخدامه في الأطفال الذين تقل أعمارهم عن ٦<br />سنوات.<br />استخدام أدوية أخرى مع هذا الدواء<br />يُرجى إبلاغ الطبيب المعالج لك أو الصيدلي الخاص بك، إذا<br />كنت تتناول أو قد تناولت مؤخرًا أية أدوية أخرى، بما في<br />ذلك الأدوية التي حصلت عليها دون وصفة طبية.<br />إذا كنت تستخدم قطرة عين أخرى في نفس وقت استخدام<br />اتبع النصائح والإرشادات الواردة في ،&trade; عقار لوكسترا<br />. نهاية القسم رقم ۳<br />السيدات الحوامل<br />إذا كنتِ حاملًا أو قد تكونين حاملًا فاستشري الطبيب<br />.&trade; المعالج لك قبل استخدام عقار لوكسترا<br />السيدات المرضعات<br />إذا كنتِ مرضعًا، استشيري الطبيب المعالج لك قبل تناول<br />أي دواء.<br />القيادة واستخدام الآلات<br />قد تصبح الرؤية مشوشة لفترة قصيرة فقط بعد استخدام<br />لذا يجب عليك تجنب القيادة أو استخدام ،&trade; عقار لوكسترا<br />الآلات حتى تتضح الرؤية مرة أخرى.<br />على كلوريد البنزالكونيوم &trade; يحتوي عقار لوكسترا<br />العدسات اللاصقة<br />- لا تستخدم قطرة العين عندما تكون العدسات اللاصقة<br />داخل العين. انتظر لمدة ۱٥ دقيقة على الأقل بعد استخدام<br />قطرة العين قبل إعادة وضع العدسات اللاصقة داخل العين.<br />عندما تكون العدسات &trade; - لا يجب استخدام عقار لوكسترا<br />اللاصقة داخل العين، حيث قد يتغير لونها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قًا لتعليمات الطبيب &trade; استخدم دائمًا عقار لوكسترا<br />المعالج لك. يُرجى مراجعة الطبيب المعالج لك أو الصيدلي<br />الخاص بك إذا لم تكن متأكدًا من طريقة الاستخدام.<br />الجرعة المعتادة هي قطرة أو قطرتان في العين (العينين)،<br />من ثلاث إلى ٤ مرات يوميًا.<br />استخدم العقار بهذا الشكل، ما لم يخبرك الطبيب المعالج لك<br />في كلتا العينين إذا &trade; بخلاف ذلك. استخدم عقار لوكسترا<br />أخبرك بذلك الطبيب المعالج لك. استمر في استخدام عقار<br />طوال المدة التي أخبرك بها الطبيب المعالج لك. &trade; لوكسترا<br />كقطرة للعين فقط. &trade; استخدم عقار لوكسترا<br />تعليمات استخدام قطرة العين<br />- اغسل يديك أولًا.<br />- قم برَج الزجاجة جيدًا قبل الاستخدام.<br />- انزع غطاء الزجاجة.<br />- قم بإمالة رأسك قليلًا إلى الخلف، ثم اسحب الجفن السفلي<br />للعين إلى أسفل لتشكيل تجويف توضع القطرة بداخله.<br />- امسك الزجاجة مقلوبة بالقرب من العين.<br />- حاول ألا تلمس عينك وأنت تقوم بهذه الخطوات.<br />- اضغط ضغطًا كافيًا لإخراج قطرة واحدة في العين.<br />- أغلق عينك لمدة دقيقة أو دقيقتين، ثم اضغط بلطف على<br />جانب الأنف حيث تلتقي زاوية العين مع الأنف. حيث يساعد<br />هذا الإجراء على وقف سيلان القطرة من موضعها ويبقيها<br />في العين.<br />- كرر هذه الخطوات في العين الأخرى، إذا كانت تحتاج<br />للعلاج أيضًا.<br />- أعد غلق الزجاجة بعد استخدامها.<br />ما هي الكمية التي يجب أن تُستخدَم:<br />حاول مرة أخرى إذا سقطت القطرة بعيدا عن العين.<br />لا تدع رأس القطارة يلمس العين أو أي شيء آخر، لتجنب<br />إيذاء العين وتلوثها.<br />إذا استخدمت كمية أكثر مما يجب من عقار<br />فيجب عليك غسل العين بماء دافئ. ،&trade; لوكسترا<br />لا تضع أي قطرات أخرى حتى يحين موعد الجرعة<br />المعتادة التالية.<br />فاستخدم قطرة واحدة ،&trade; إذا أغفلت استخدام عقار لوكسترا<br />بمجرد تذكرك لهذا الأمر، ثم استمر في الجرعات المُعتادة.<br />لا تستخدم جرعة مضاعفة لتعويض الجرعة التي أغفلتها.<br />إذا كنت تستخدم قطرة عين أخرى، فانتظر لفترة تتراوح من<br />خمس إلى عشر دقائق على الأقل بين وضع قطرة<br />وغيرها من القطرات الأخرى. &trade; عقار لوكسترا<br />إذا شرب أي شخص هذا الدواء عن طريق الخطأ، يُرجى<br />استشارة الطبيب المعالج لك فورًا.<br />حتى يخبرك &trade; لا تتوقف عن استخدام عقار لوكسترا<br />الطبيب المعالج لك بأن تفعل ذلك.</p><p>إذا كان لديك أي أسئلة أخرى حول هذا المستحضر، فاستشر<br />الطبيب المعالج لك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثله مثل كافة الأدوية، يمكن أن يسبب عقار لوكسترا<br />جانبية، على الرغم من عدم حدوثها لدى جميع المرضى.<br />الآثار الجانبية<br />۱)، آثار / فئات معدل التكرار: آثار جانبية شائعة جدًّا (&ge; ۱۰<br />۱)، آثار جانبية غير / ۱ إلى &lt; ۱۰ / جانبية شائعة (&ge; ۱۰۰<br />۱)، آثار جانبية نادرة (&ge; / ۱ إلى &lt; ۱۰۰ / شائعة (&ge; ۱,۰۰۰<br />۱)، آثار جانبية نادرة جدًّا / ۱ إلى &lt; ۱,۰۰۰ /۱۰,۰۰۰<br />۱)، آثار جانبية غير معروف معدل تكرارها /۱۰,۰۰۰&gt;)<br />(لا يمكن تقدير معدل تكرارها من واقع البيانات المتاحة).<br />اضطرابات الجهاز المناعي:<br />آثار جانبية غير معروف معدل تكرارها: حساسية مفرطة،<br />أرتكاريا<br />اضطرابات الجهاز العصبي:<br />آثار جانبية غير معروف معدل تكرارها: صداع، دوخة<br />اضطرابات العين:<br />آثار جانبية شائعة: تهيُّج العين، شعور غير مريح بالعين.<br />آثار جانبية غير معروف معدل تكرارها: ارتفاع الضغط<br />داخل العين، مياه بيضاء &quot;كاتاراكت&quot; (بما في ذلك المنطقة<br />تَحْتَ المِحْفَظَة)، التهاب القرنية، التهاب المُلْتَحِمَة، تورم<br />الجفن وإحساس بوجود جسم غريب في العين، زيادة<br />الإدماع، جفاف العين، ألم بالعين، احتقان العين، وذمة<br />محيطة بالحجاج (بما في ذلك تورم الجفن)، اختراق العين<br />(الصلبة أو ثقب القرنية)، عدوى العين (بما في ذلك العدوى<br />البكتيرية والفطرية والفيروسية)، لسعان بالعين، تهيج العين،<br />عدم وضوح الرؤية/اضطرابات الرؤية، توسع حدقة العين<br />اضطرابات الجهاز الهضمي:<br />آثار جانبية غير معروف معدل تكرارها: اضطراب بحاسة<br />التَّذوق، غثيان.<br />اضطرابات الجلد والنسيج الموجود أسفل الجلد.<br />آثار جانبية غير معروف معدل تكرارها: حكة، طفح جلدي،<br />متلازمة ستيفنز جونسون، انحلال البشرة النخري التَّسَمُّمِيّ<br />(TEN)<br />آثار جهازية: قد يؤدي الاستخدام الموضعي المكثف من<br />الكورتيكوستيرويدات إلى حدوث آثار جانبية متعلقة بأجهزة<br />الجسم.<br />يُمكِنك عادة مواصلة استخدام القطرة، ما لم تكن الآثار<br />الجانبية خطيرة. إذا أصبحت أيٌّ من الآثار الجانبية خطيرة،<br />أو إذا لاحظت أية آثار جانبية غير المدرجة في هذه النَّشرة،<br />فيُرجى إبلاغ الطبيب المعالج لك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; يحفظ بعيداًعن متناول الأطفال .<br />&bull; يحفظ في درجة حرارة لاتزيد عن ۳۰ درجة مئوية.<br />تكون معقمة عند فتحها لأول &trade; &bull; قطرات العين لوكسترا<br />مرة، من المهم أن تظل القطرات نظيفة بأكبر قدر ممكن<br />خلال الاستخدام.<br />&bull; لا يستعمل الدواء بعد ۳۰ يوما من تاريخ فتح الزجاجة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما هي مكونات لوكسترا<br />هي قطرة للعين تحتوى كل مل على المواد &trade; &bull; لوكسترا<br />الفعالة: أوفلوكساسين ۳ ملجم، أسيتات البريدنيزولون ۲<br />ملجم، هيدروكلوريد التيتراهيدروزولين ۰٫٤ ملجم .<br />المكونات الآخرى: كلوريد البنزالكونيوم، كلوريد الصوديوم،<br />هيدروكسي بروبيل ميثيل سليلوز، ماء للحقن، حمض<br />)1N 1 و / أو هيدروكسيد الصوديوم N الهيدروكلوريك<br />.(pH لضبط درجة الحموض</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>معلق للعين لونه مائل للأبيض إلي الأصفر &trade; &bull;لوكسترا<br />الفاتح.<br />معلق للعين ٥ مل في قطارة من البولي إيثيلين &trade; &bull;لوكسترا<br />منخفض الكثافة.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>اسم وعنوان مالك رخصة التسويق و المصنع:<br />شركة مصنع جمجوم للأدوية،<br />جدة، المملكة العربية السعودية.<br />+۹٦٦-۱۲- الهاتف: ٦۰۸۱۱۱۱<br />+۹٦٦-۱۲- فاكس: ٦۰۸۱۲۲۲<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبيه:<br />&bull; المملكة العربية السعودية:<br />- المركز الوطني للتيقظ و السلامة الدوائية<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />للإتصال بالإدارة التنفيذية للتيقظ وإدارة الأزمات. o<br />+۹٦٦-۱۱- هاتف: ۲۰۳۸۲۲۲<br />۲۳٤۰-۲۳۳٤-۲۳٥٤-۲۳٥۳-۲۳٥٦- تحويلة: ۲۳۱۷<br />الهاتف المجاني: ۸۰۰۲٤۹۰۰۰۰ o<br />npc.drug@sfda.gov.sa : بريد إلكتروني o<br />www.sfda.gov.sa/npc : الموقع الالكتروني o</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            06/2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Loxtra Ophthalmic Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ml of Loxtra contains:
 Ofloxacin 3.0 mg,
 Prednisolone acetate 2.0 mg,
 Tetrahydrozoline hydrochloride 0.4mg,
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sterile Ophthalmic Suspension
Off white to light yellow suspension, free from visible contamination, filled in 10 mL LDPE
opaque bottles.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Loxtra is prescribed for corticosteroid responsive inflammatory conditions of the conjunctiva,<br />cornea and anterior segment of the eye where bacterial infection or a risk of bacterial infection<br />exists.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Loxtra is to be used only as eye drops. Instill 1-2 drops in to the conjunctival sac of the eye (s)<br />three to four times daily or as directed by the physician.</p><p>Instructions for using eye drops<br /> Shake the bottle well before use.<br /> Unscrew the cap from the bottle, check the dropper is clean.<br /> Pull your lower eyelid gently down, and then carefully instill one drop inside the lower<br />eyelid, in the corner closest to the nose.<br /> Release the lower eyelid, and blink a few times to make sure the eye is covered by the<br />liquid.<br /> Repeat the procedure for your other eye, if it also needs treatment.</p><p>When you have finished, replace the protective cap tightly to prevent spilling or<br />spoilage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prednisolone Acetate
Acute untreated purulent ocular infections. Acute superficial herpes simplex (dendritic
keratitis); vaccinia, varicella and most other viral diseases of the cornea and conjunctiva. Fungal
diseases of the eye. Mycobacterial infection such as tuberculosis of the eye
Ofloxacin
Contra-indicated in individuals who have shown hypersensitivity to ofloxacin, any of its
excipients or any other quinolones.
Tetrahydrozoline Hydrochloride
Known hypersensitivity to tetrahydrozoline or any ingredient in the formulation
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prednisolone Acetate<br />Acute purulent infections of the eye may be masked or enhanced by the use of topical steroids.<br />Prolonged use may also suppress the host immune response and thus increase the hazard of<br />secondary ocular infections.<br />Fungal infections of the cornea have been reported coincidentally with long-term steroid<br />application and fungal invasion may be suspected in any persistent corneal ulceration where a<br />steroid has been used, or is in use.<br />Various ocular diseases and long-term use of topical corticosteroids have been known to cause<br />corneal or scleral thinning. Use of topical corticosteroids in the presence of thin corneal or<br />scleral tissue may lead to perforation.<br />The preservative benzalkonium chloride, may be absorbed by and cause discoloration of soft<br />contact lenses. Patients wearing soft contact lenses should be instructed to remove contact<br />lenses prior to administration of the solution and wait at least 15 minutes after instilling Loxtra<br />before reinserting soft contact lenses.<br />Use of intraocular steroids may prolong the course and may exacerbate the severity of many<br />viral infections on the eye (including herpes simplex). Patients with a history of herpes simplex<br />keratitis should be treated with caution. Use of steroid medication in the presence of stromal</p><p>herpes simplex requires caution and should be followed by frequent, mandatory, slit-lamp<br />microscopy.<br />Prolonged use of topical corticosteroids may cause an increase in intraocular pressure in certain<br />individuals. This may result in glaucoma with damage to the optic nerve with resultant defects<br />in visual acuity and visual fields. Steroids should be used with caution in the presence of<br />glaucoma. It is advisable that intraocular pressure be checked frequently during treatment with<br />Loxtra. Eye drops containing corticosteroids should not be used for more than 10 days except<br />under strict ophthalmic supervision with regular checks for intraocular pressure.<br />Posterior subcapsular cataract formation has been reported after heavy or protracted use of<br />topical ophthalmic corticosteroids.<br />The use of steroids after cataract surgery may delay healing and increase the incidence of bleb<br />formation.<br />Systemic adverse events may occur with extensive use of topical steroids; punctal occlusion<br />may be recommended.<br />The possibility of adrenal suppression should be considered with prolonged, frequent, use of<br />high dose topical steroids, particularly in infants and children.<br />To prevent eye injury or contamination, care should be taken to avoid touching the bottle tip to<br />the eye or to any other surface.<br />Visual disturbance<br />Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient<br />presents with symptoms such as blurred vision or other visual disturbances, the patient should<br />be considered for referral to an ophthalmologist for evaluation of possible causes which may<br />include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR)<br />which have been reported after use of systemic and topical corticosteroids.<br />Ofloxacin<br />Safety and effectiveness in infants below the age of one year have not been established.<br />Serious and occasionally fatal hypersensitivity (anaphylactic/anaphylactoid) reactions, some<br />following the first dose, have been reported in patients receiving systemic quinolones, including<br />ofloxacin. Some reactions were accompanied by cardiovascular collapse, loss of consciousness,<br />angioedema (including laryngeal, pharyngeal or facial oedema), airway obstruction, dyspnoea,<br />urticaria, and itching.<br />If an allergic reaction to Ofloxacin occurs, discontinue the drug. Use Ofloxacin with caution in<br />patients who have exhibited sensitivities to other quinolones antibacterial agents.<br />When using Ofloxacin the risk of rhinopharyngeal passage which can contribute to the<br />occurrence and the diffusion of bacterial resistance should be considered. As with other antiinfectives,<br />prolonged use may result in overgrowth of non-susceptible organisms.&nbsp;If worsening infection occurs, or if clinical improvement is not noted within a reasonable period,<br />discontinue use and institute alternative therapy.<br />Cardiac disorders<br />Caution should be taken when using fluoroquinolones, including Ofloxacin in patients with<br />known risk factors for prolongation of the QT interval such as, for example:<br />- Congenital long QT syndrome<br />- Concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III<br />anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics)<br />- Uncorrected electrolyte imbalance (e.g. hypokalaemia, hypomagnesaemia)<br />- Cardiac disease (e.g. heart failure, myocardial infarction, bradycardia)<br />Elderly patients and women may be more sensitive to QTc-prolonging medications. Therefore,<br />caution should be taken when using fluoroquinolones, including Ofloxacin, in these<br />populations.<br />Use Ofloxacin with caution in patients who have exhibited sensitivities to other quinolone<br />antibacterial agents.<br />Data are very limited to establish efficacy and safety of Ofloxacin eye drops 0.3% in the<br />treatment of conjunctivitis in neonates.<br />The use of Ofloxacin eye drops in neonates with ophthalmia neonatorum caused by Neisseria<br />gonorrhoeae or Chlamydia trachomatis is not recommended as it has not been evaluated in such<br />patients.<br />Use in elderly: No comparative data are available with topical dosing in elderly versus other<br />age groups.<br />Clinical and non-clinical publications have reported the occurrence of corneal perforation in<br />patients with pre-existing corneal epithelial defect or corneal ulcer, when treated with topical<br />fluoroquinolone antibiotics. However, significant confounding factors were involved in many<br />of these reports, including advanced age, presence of large ulcers, concomitant ocular<br />conditions (e.g. severe dry eye), systemic inflammatory diseases (e.g. rheumatoid arthritis), and<br />concomitant use of ocular steroids or non-steroidal anti-inflammatory drugs. Nevertheless, it is<br />necessary to advise caution regarding the risk of corneal perforation when using product to treat<br />patients with corneal epithelial defects or corneal ulcers.<br />Corneal precipitates have been reported during treatment with topical ophthalmic Ofloxacin.<br />However, a causal relationship has not been established.<br />Long-term, high-dose use of other fluoroquinolones in experimental animals has caused<br />lenticular opacities. However, this effect has not been reported in human patients, nor has it<br />been noted following topical ophthalmic treatment with Ofloxacin for up to six months in<br />animal studies including studies in monkeys.&nbsp;Ofloxacin contains the preservative benzalkonium chloride which may cause ocular irritation<br />and discolour soft contact lenses.<br />Sun or UV-exposition should be avoided during use of Ofloxacin due to the potential for<br />photosensitivity.<br />Use of contact lenses is not recommended in patients receiving treatment for an eye infection.<br />Tetrahydrozoline Hydrochloride<br />Glaucoma<br />Patients with narrow-angle glaucoma or other serious eye disease should consult a clinician<br />before using ophthalmic solution.102 a c<br />General Precautions<br />Overuse: Possible irritation of conjunctiva and adverse systemic effects (particularly in<br />children) with excessive dosage and/or prolonged or too frequent use. Possible ocular<br />hyperemia (redness); avoid prolonged use.101 102 a c (See Advice to Patients.)<br />Overdose may produce CNS depression with drowsiness, decreased body temperature,<br />bradycardia, shock-like hypotension, apnea, and coma.<br />Accidental ingestion of imidazoline derivatives (i.e., tetrahydrozoline, naphazoline,<br />oxymetazoline) in children has resulted in serious adverse events requiring hospitalization (e.g.,<br />coma, bradycardia, decreased respiration, sedation, somnolence).<br />High concentrations of ophthalmic solution may liberate pigment granules; more common in<br />the elderly.<br />Sympathomimetic Effects<br />Possible headache, hypertension, weakness, sweating, cardiac irregularities (e.g., palpitations),<br />tremors, drowsiness, lightheadedness, and insomnia. Use with caution in patients with thyroid<br />disease (e.g., hyperthyroidism), heart disease (e.g., coronary artery disease), hypertension, or<br />diabetes mellitus.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prednisolone Acetate<br />None known.<br />Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to<br />increase the risk of systemic side-effects.<br />Ofloxacin<br />No interaction studies have been performed.<br />It has been shown that the systemic administration of some quinolones inhibits the metabolic<br />clearance of caffeine and theophylline. Drug interaction studies conducted with systemic<br />ofloxacin have demonstrated that metabolic clearance of caffeine and theophylline are not<br />significantly affected by ofloxacin.<br />Although there have been reports of an increased prevalence of CNS toxicity with systemic<br />dosing of fluoroquinolones when used concomitantly with systemic nonsteroidal antiinflammatory<br />drugs (NSAIDs), this has not been reported with the concomitant systemic use of<br />NSAIDs and ofloxacin.<br />Ofloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs<br />known to prolong the QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic<br />antidepressants, macrolides, antipsychotics).<br />Tetrahydrozoline Hydrochloride<br />None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prednisolone Acetate<br />Pregnancy<br />There is inadequate evidence of safety in human pregnancy. Administration of corticosteroids<br />to pregnant animals can cause abnormalities of fetal development including cleft palate and<br />intra-uterine growth retardation. There may therefore be a very small risk of such defects in the<br />human fetus. Therefore this product should be used with caution during pregnancy only if the<br />potential benefit outweighs the potential risk to the fetus.<br />Breast-feeding&nbsp;It is not known whether topical administration of Prednisolone acetate could result in sufficient<br />systemic absorption to produce detectable quantities in breast milk. Therefore, use is not<br />recommended in women breast- feeding infants.<br />Ofloxacin<br />Use in pregnancy: There have been no adequate and well-controlled studies performed in<br />pregnant women. Since systemic quinolones have been shown to cause arthropathy in immature<br />animals, it is recommended that Ofloxacin not be used in pregnant women.<br />Use during lactation: Because ofloxacin and other quinolones taken systemically are excreted<br />in breast milk, and there is potential for harm to nursing infants, a decision should be made<br />whether to temporarily discontinue nursing or not to administer the drug, taking into account<br />the importance of the drug to the mother.<br />Tetrahydrozoline Hydrochloride<br />Pregnancy: Category C.<br />Lactation: Not known whether tetrahydrozoline is distributed into milk. Caution if used in<br />nursing women.<br />Pediatric Use: Safety and efficacy of ophthalmic solution not established in children &lt;6 years<br />of age. Accidental ingestion of OTC ophthalmic solutions or nasal sprays containing<br />imidazoline derivatives (i.e., tetrahydrozoline, naphazoline, oxymetazoline) in children has<br />resulted in serious adverse events requiring hospitalization, including nausea, vomiting,<br />lethargy, tachycardia, decreased respiration, bradycardia, hypotension, hypertension, sedation,<br />somnolence, mydriasis, stupor, hypothermia, drooling, and coma. Respiratory depression, CNS<br />depression, and/or lethargy reportedly occurred in infants following accidental ingestion of<br />small amounts (&le;6 mL) of 0.05% tetrahydrozoline ophthalmic solution. Keep out of reach of<br />children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prednisolone acetate may cause short-lasting blurring of vision upon instillation. If affected,<br />the patient should not use machinery/electric tools or drive until vision has returned to normal.<br />Ofloxacin<br />No studies on the effects on the ability to drive and use machines have been performed&nbsp;Transient blurring of vision may occur on instillation of eye drops. Do not drive or operate<br />hazardous machinery unless vision is clear.<br />Tetrahydrozoline Hydrochloride<br />None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prednisolone Acetate<br />The following undesirable effects have been reported following use of Prednisolone Acetate<br />Frequency categories: very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000<br />to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), not known (cannot be estimated<br />from available data).<br />Immune system disorders<br />Not known: Hypersensitivity, Urticaria<br />Nervous system disorders<br />Not known: Headache<br />Eye disorders<br />Not known: Intraocular pressure increased<br />Cataract (including subcapsular)<br />Eye penetration (scleral or corneal perforation)<br />Foreign body sensation<br />Ocular infection (including bacterial*, fungal*, and viral* infections)<br />Ocular stinging<br />Eye irritation<br />Ocular hyperemia<br />Vision blurred/Visual impairment<br />Mydriasis<br />Gastrointestinal disorders<br />Not known: Dysgeusia<br />Skin and subcutaneous tissue disorders<br />Not known: Pruritus, Rash<br />Systemic: extensive topical use of corticosteroids may lead to systemic side effects*.&nbsp;Ofloxacin<br />General<br />Serious reactions after use of systemic ofloxacin are rare and most symptoms are reversible.<br />Since a small amount of ofloxacin is systemically absorbed after topical administration, sideeffects<br />reported with systemic use could possibly occur.<br />Frequency categories: Very common (&ge;1/10); Common (&ge;1/100 to &lt;1/10); Uncommon<br />(&ge;1/1,000 to &lt;1/100); Rare (&ge;1/10,000 to &lt;1/1,000); Very rare (&lt;1/10,000) and not known<br />(cannot be estimated from the available data):<br />Immune System Disorders<br />Not Known: Hypersensitivity reaction including signs or symptoms of Eye allergy (such as Eye<br />pruritus and Eyelid pruritus) and anaphylactic reactions (such as angioedema, dyspnea,<br />anaphylactic shock, oropharyngeal swelling, facial edema and tongue swollen)<br />Nervous System Disorders<br />Not known: Dizziness<br />Eye Disorders<br />Common: Eye irritation; Ocular discomfort<br />Not known: Keratitis; Conjunctivitis; Vision blurred; Photophobia; Eye edema; Foreign body<br />sensation in eyes; Lacrimation increased; Dry eye; Eye pain; Ocular hyperaemia; Periorbital<br />edema (including eyelid edema)<br />Cardiac disorders<br />Not known: ventricular arrhythmia and torsades de pointes (reported predominantly in patients<br />with risk factors for QT prolongation); ECG QT prolonged. Gastrointestinal Disorders<br />Not known: Nausea<br />Skin and Subcutaneous Tissue Disorders<br />Not Known: Stevens-Johnson syndrome; Toxic epidermal necrolysis<br />Tetrahydrozoline Hydrochloride<br />Ophthalmic: Blurred vision, irritation, mydriasis</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prednisolone Acetate<br />There is no clinical experience of overdosage. Acute overdosage is unlikely to occur via the<br />ophthalmic route<br />Ofloxacin<br />In the event of overdose, symptomatic treatment should be implemented. ECG monitoring<br />should be undertaken, because of the possibility of QT interval prolongation<br />Tetrahydrozoline Hydrochloride<br />None known.&nbsp;To report any side effect(s):<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5.1 Pharmacodynamic properties<br />Prednisolone Acetate<br />Pharmacotherapeutic group: corticosteroids, ATC code: S01BA04.<br />Prednisolone acetate is a synthetic adrenocorticoid with the general properties of prednisolone.<br />Adrenocorticoids diffuse across cell membranes to complex with cytoplasmic receptors and<br />subsequently stimulate synthesis of enzymes with anti-inflammatory effects. Glucocorticoids<br />inhibit the edema, fibrin deposition, capillary dilation and phagocytic migration of the acute<br />inflammatory response as well as capillary proliferation, deposition of collagen and scar<br />formation. Prednisolone acetate has, on a weight to weight basis, a potency three to five times<br />that of hydrocortisone&nbsp;Ofloxacin<br />Pharmacotherapeutic group: Ophthalmologicals, anti-infectives, fluoroquinolones<br />ATC code: S01AE01.<br />Ofloxacin is a synthetic fluorinated 4-quinolone antibacterial agent with activity against a broad<br />spectrum of Gram negative and to a lesser degree Gram positive organisms.<br />Ofloxacin has been shown to be active against most strains of the following organisms both in<br />vitro and clinically in ophthalmic infections. Clinical trial evidence of the efficacy of Ofloxacin<br />against S. pneumoniae was based on a limited number of isolates.<br />Gram-negative bacteria: Acinetobacter calcoaceticus var. anitratum, and A. calcoaceticus var.<br />iwoffi; Enterobacter Sp. including E. cloacae; Haemophilis Sp, including H. influenza and H.<br />aegyptius; Klebsiella Sp., including K. Pneumoniae; Moraxella Sp., Morganella morganii;<br />Proteus Sp., including P. Mirabilis; Pseudomonas Sp.; including P. Aeruginosa, P. cepacia, and<br />P. fluoroscens; and Serratia Sp., including S. marcescens.<br />Gram-positive bacteria: Bacillus Sp.; Corynebacterium Sp.; Micrococcus Sp.; Staphylococcus<br />Sp., including S. aureus and S. epidermidis; Streptococcus Sp., including S. Pneumoniae (see<br />above), S. viridans and Beta-haemolytic.<br />The primary mechanisms of action is through inhibition of bacterial DNA gyrase, the enzyme<br />responsible for maintaining the structure of DNA.<br />Ofloxacin is not subject to degradation by beta-lactamase enzymes nor is it modified by<br />enzymes such as aminoglycoside adenylases or phosphorylases, or chloramphenicol<br />acetyltransferase.<br />Tetrahydrozoline Hydrochloride<br />Structurally and pharmacologically related to naphazoline, oxymetazoline, and xylometazoline.<br />Directly stimulates &alpha;-adrenergic receptors; exerts little or no effect on &beta;-adrenergic receptors.<br />Conjunctival application constricts small arterioles and temporarily relieves conjunctival<br />congestion.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5.2 Pharmacokinetic properties<br />Prednisolone Acetate<br />Prednisolone acetate has been shown to penetrate rapidly the cornea after topical application of<br />a suspension preparation. Aqueous humour Tmax occurs between 30 and 45 minutes after<br />installation. The half-life of prednisolone acetate in human aqueous humour is approximately<br />30 minutes.<br />Ofloxacin<br />After ophthalmic instillation, ofloxacin is well maintained in the tear-film.&nbsp;In a healthy volunteer study, mean tear film concentrations of ofloxacin measured four hours<br />after topical dosing (9.2 &mu;g/g) were higher than the 2&mu;g/ml minimum concentration of ofloxacin<br />necessary to inhibit 90% of most ocular bacterial strains (MIC90) in-vitro.<br />Maximum serum ofloxacin concentrations after ten days of topical dosing were about 1000<br />times lower than those reported after standard oral doses of ofloxacin, and no systemic sideeffects<br />attributable to topical ofloxacin were observed.<br />Tetrahydrozoline Hydrochloride<br />Bioavailability<br />Absorption may occasionally be sufficient to produce systemic effects.<br />Onset<br />Following ocular administration, local vasoconstriction usually occurs within minutes.<br />Duration<br />Local vasoconstriction may persist for 4&ndash;8 hours</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prednisolone Acetate<br />Non-clinical data reveal no special hazard for humans based on conventional studies on the<br />acute toxic potential of Prednisolone acetate.<br />Ofloxacin<br />There are no toxicological safety issues with this product in man as the level of systemic<br />absorption from topical ocular administration of ofloxacin is minimal.<br />Animal studies in the dog have found cases of arthropathy in weight bearing joints of juvenile<br />animals after high oral doses of certain quinolones. However, these findings have not been seen<br />in clinical studies and their relevance to man is unknown.<br />Tetrahydrozoli</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1. Benzalkonium Chloride<br />2. Sodium Chloride<br />3. Hydroxypropylmethyl cellulose<br />4. Water for Injection<br />5. Hydrochloric acid 1N and/or Sodium Hydroxide 1N (to adjust pH)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
Shelf-life after first opening
Discard after 30 days of opening
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30⁰C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>LDPE (Low Density Polyethylene) bottle with screw caps contains 5ml of Loxtra Ophthalmic<br />Suspension.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p> Keep out of reach of children.<br /> LoxtraTM eye drops are sterile when first opened, it is important to keep the drops as<br />clean as possible during use.<br /> Discard after 30 days of opening.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Plot No. ME 1:3, Phase V, Industrial City, Jeddah
Postal address:
P.O. Box 6267
Jeddah 21442, Saudi Arabia.
Tel: 00966-12-6081111
Fax: 00966-12-6081222
E-mail: jpharma@jamjoompharma.com
Website: www.jamjoompharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>